July 23, 2025 a 07:43 pm

KVUE: Fundamental Ratio Analysis - Kenvue Inc.

Kenvue Inc. Analysis

Kenvue Inc., a subsidiary of Johnson & Johnson, operates in the consumer health space, with a diversified portfolio across self-care, skin health and beauty, and essential health segments. The company's stock is under close analysis for its stability and performance in the consumer defensive sector. Investment in KVUE could offer steady returns given its solid presence in personal and household products.

Fundamental Rating

Kenvue Inc.'s stock currently holds a B- rating, indicating a moderate performance with potential growth prospects. Below are the fundamental scores:

Category Score Visual
Discounted Cash Flow 3
Return on Equity 3
Return on Assets 3
Debt to Equity 2
Price to Earnings 1
Price to Book 2

Historical Rating

There has been a slight change in the overall score indicating some shifts in the company's financial health. Here are the ratings over time:

Date Overall DCF ROE ROA D/E P/E P/B
2025-07-23 2 3 3 3 2 1 2
N/A 0 3 3 3 2 1 2

Analyst Price Targets

Analysts estimate varying price targets for KVUE, with a consensus that the stock is likely to maintain its range:

High Low Median Consensus
29 23 26 26
KVUE stock chart

Analyst Sentiment

The overall analyst sentiment shows a conservative stance with no aggressive buy or sell suggestions:

Recommendation Count Visual
Strong Buy 0
Buy 4
Hold 7
Sell 0
Strong Sell 0

Conclusion

Kenvue Inc. shows stability in its fundamental measures, supported by a recognized parent company and a diverse product lineup within the consumer health sector. With a "Hold" consensus, the stock presents limited immediate growth potential but offers steady performance chances. Investors should consider market dynamics and sector trends before taking positions. Overall, KVUE is a reliable stock for those focusing on long-term, stable returns in a defensive industry.